C2N Diagnostics

Saint Louis, MO · Founded 2007 · Privately Held (backing)

Provider of specialty diagnostic testing services intended to offer novel diagnostics for Alzheimer's disease. C2N Diagnostics is based in Saint Louis, MO and was founded in 2007. It has raised $95 million across 2 recorded rounds; the latest was a $10 million early-stage round in May 2025.

Last price · $/share
—
Implied valuation
—
Total raised
$95.0M
Last round
Early Stage VC
May 2025
How much has C2N Diagnostics raised?
$95.0Macross 2 recorded rounds · Mar 2024 – May 2025

Most recently, C2N Diagnostics raised $10.0M in its Early Stage VC (May 2025).

Free account
More of C2N Diagnostics with a free account
  • ·Watch C2N Diagnostics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

C2N Diagnostics round by round

2 rounds
May 2025Early Stage VC$10.0MSEC filing▮
1 investors participated
Mar 2024Early Stage VC$25.0MSEC filing▮
3 investors participated

How much has C2N Diagnostics raised?

C2N Diagnostics has raised $95 million in total; 2 of its rounds are on record. The largest on record was a $10 million early-stage round in May 2025.

C2N Diagnostics has filed 3 Form Ds with the SEC since 2024, most recently in May 2025 ($10 million sold to 1 investor).

C2N Diagnostics investors

9 investors are on record for C2N Diagnostics, including Samsung Venture Investment, Washington University in St. Louis, GHR Foundation and Alzheimers Drug Discovery Foundation. The early-stage round in May 2025 drew 1 investor.

For fundraisers
Raising for a company like C2N Diagnostics?

9 investors have backed C2N Diagnostics.

See all 9 investors →

Frequently asked about C2N Diagnostics

How much has C2N Diagnostics raised?
C2N Diagnostics has raised $95.0M in total across 2 recorded funding rounds.
When was C2N Diagnostics's last funding round?
C2N Diagnostics's most recent recorded round was Early Stage VC in May 2025, raising $10.0M.